Screener
ClearPoint Neuro CLPT Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash, cash equivalents and restricted cash, beginning of period | 46,973 | 20,104 |
| Cash, cash equivalents and restricted cash, end of period | $36,516 | $12,387 |
| Cash and cash equivalents | 35,593 | 12,387 |
| Restricted cash included in other current assets and other assets, non-current | 923 | — |
| Total cash, cash equivalents and restricted cash | $36,516 | $12,387 |
| SUPPLEMENTAL CASH FLOW INFORMATION | ||
| Cash paid for: | ||
| Income taxes | — | — |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's restricted cash?
- ClearPoint Neuro (CLPT) reported restricted cash of $923K in Q1 2026.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about ClearPoint Neuro's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude